SDZ 63441
Alternative Names: SRI 63441Latest Information Update: 25 Mar 1996
At a glance
- Originator Novartis
- Class Antithrombotics
- Mechanism of Action Platelet activating factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias